Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study

BACKGROUND: Inhaled corticosteroids are a mainstay of therapy for persistent asthma, but suboptimal adherence with twice-daily use is widespread. Fluticasone furoate (FF) is a new inhaled corticosteroid (ICS) suitable for once-daily dosing in asthma. This study was performed to descriptively assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodcock, Ashley, Lötvall, Jan, Busse, William W, Bateman, Eric D, Stone, Sally, Ellsworth, Anna, Jacques, Loretta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107726/
https://www.ncbi.nlm.nih.gov/pubmed/25007865
http://dx.doi.org/10.1186/1471-2466-14-113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107726/
https://www.ncbi.nlm.nih.gov/pubmed/25007865
http://dx.doi.org/10.1186/1471-2466-14-113

Ejemplares similares